全文获取类型
收费全文 | 1071113篇 |
免费 | 77722篇 |
国内免费 | 2343篇 |
专业分类
耳鼻咽喉 | 15538篇 |
儿科学 | 32129篇 |
妇产科学 | 30882篇 |
基础医学 | 151891篇 |
口腔科学 | 31468篇 |
临床医学 | 93372篇 |
内科学 | 202057篇 |
皮肤病学 | 21678篇 |
神经病学 | 83171篇 |
特种医学 | 45998篇 |
外国民族医学 | 259篇 |
外科学 | 167875篇 |
综合类 | 26193篇 |
现状与发展 | 2篇 |
一般理论 | 301篇 |
预防医学 | 85951篇 |
眼科学 | 25019篇 |
药学 | 79157篇 |
2篇 | |
中国医学 | 1761篇 |
肿瘤学 | 56474篇 |
出版年
2018年 | 11292篇 |
2017年 | 10013篇 |
2016年 | 10109篇 |
2015年 | 13009篇 |
2014年 | 16095篇 |
2013年 | 21248篇 |
2012年 | 34040篇 |
2011年 | 30237篇 |
2010年 | 17090篇 |
2009年 | 17798篇 |
2008年 | 26325篇 |
2007年 | 29196篇 |
2006年 | 29188篇 |
2005年 | 36508篇 |
2004年 | 37463篇 |
2003年 | 32301篇 |
2002年 | 26668篇 |
2001年 | 40185篇 |
2000年 | 38553篇 |
1999年 | 36488篇 |
1998年 | 10073篇 |
1997年 | 9094篇 |
1996年 | 9077篇 |
1992年 | 33166篇 |
1991年 | 32805篇 |
1990年 | 32525篇 |
1989年 | 31239篇 |
1988年 | 29330篇 |
1987年 | 28801篇 |
1986年 | 27306篇 |
1985年 | 26066篇 |
1984年 | 19885篇 |
1983年 | 16778篇 |
1982年 | 9874篇 |
1981年 | 9016篇 |
1980年 | 8543篇 |
1979年 | 20269篇 |
1978年 | 14343篇 |
1977年 | 11854篇 |
1976年 | 10868篇 |
1975年 | 12483篇 |
1974年 | 15590篇 |
1973年 | 14796篇 |
1972年 | 14165篇 |
1971年 | 13307篇 |
1970年 | 12680篇 |
1969年 | 12239篇 |
1968年 | 11061篇 |
1967年 | 10316篇 |
1966年 | 9521篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
Turnbull Chris D. Stockley James A. Madathil Shyam Huq Syed S. A. Cooper Brendan G. Ali Asad Wharton Simon Stradling John R. Heitmar Rebekka 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(7):2129-2139
Graefe's Archive for Clinical and Experimental Ophthalmology - Retinal microvascular endothelial dysfunction is thought to be of importance in the development of ocular vascular diseases.... 相似文献
63.
64.
65.
Conan MacDougall Theora Canonica Chris Keh Binh An P. Phan Janice Louie 《Pharmacotherapy》2022,42(4):343-361
Rifamycins (rifampin, rifabutin, and rifapentine) play an essential role in the treatment of mycobacterial and some nonmycobacterial infections. They also induce the activity of various drug transporting and metabolizing enzymes, which can impact the concentrations and efficacy of substrates. Many anticoagulant and antiplatelet (AC/AP) agents are substrates of these enzymes and have narrow therapeutic indices, leading to risks of thrombosis or bleeding when coadministered with rifamycins. The objective of this systematic review was to evaluate the effects on AC/AP pharmacokinetics, laboratory markers, and clinical safety and efficacy of combined use with rifamycins. A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidance was performed. The PubMed, Embase, and Web of Science databases were queried for English-language reports on combination use of rifamycins and AC/AP agents from database inception through August 2021. The 29 studies identified examined warfarin (n = 17), direct oral anticoagulants (DOACs) (n = 8), and antiplatelet agents (n = 4) combined with rifampin (n = 28) or rifabutin (n = 1). Eleven studies were case reports or small case series; 14 reported on pharmacokinetic or laboratory markers in healthy volunteers. Rifampin-warfarin combinations led to reductions in warfarin area under the curve (AUC) of 15%–74%, with variability by warfarin isomer and study. Warfarin dose increases of up to 3–5 times prerifampin doses were required to maintain coagulation parameters in the therapeutic range. DOAC AUCs were decreased by 20%–67%, with variability by individual agent and with rifampin versus rifabutin. The active metabolite of clopidogrel increased substantially with rifampin coadministration, whereas prasugrel was largely unaffected and ticagrelor saw decreases. Our review suggests most combinations of AC/AP agents and rifampin are problematic. Further studies are required to determine whether rifabutin or rifapentine could be safe alternatives for coadministration with AC/AP drugs. 相似文献
66.
67.
68.
W. Do T. Elzerman R. de Bree A. Rosenberg T. Forouzanfar E.M. Van Cann 《International journal of oral and maxillofacial surgery》2021,50(5):591-597
The aim of this study was to analyse the effect of body mass index (BMI), both low and high values, on the perioperative complication rate in patients with oral squamous cell carcinoma (OSCC). The medical records of 259 patients operated between 2014 and 2017 for OSCC were reviewed. Univariate and multivariate analyses were performed. Sixty of the 259 patients developed 87 complications. Low or high BMI was not associated with the perioperative complication rate. A longer operating time and increased blood loss were associated with a higher perioperative complication rate and higher Clavien–Dindo grade. Low BMI, American Society of Anesthesiologists score 2 and 3, a longer operating time, and increased blood loss were associated with a longer hospital stay. Low BMI was associated with a longer hospital stay. Neither low nor high BMI was associated with the perioperative complication rate. A longer operating time and increased blood loss were associated with a higher perioperative complication rate and higher Clavien–Dindo grade. 相似文献
69.
Michael W. Manning Yi-Ju Li Dean Linder John C. Haney Yi-Hung Wu Mihai V. Podgoreanu Madhav Swaminathan Jacob N. Schroder Carmelo A. Milano Ian J. Welsby Mark Stafford-Smith Kamrouz Ghadimi 《Journal of cardiothoracic and vascular anesthesia》2021,35(5):1310-1318
- Download : Download high-res image (215KB)
- Download : Download full-size image
70.
Erik de Bakker Mirthe A. M. van der Putten Martijn W. Heymans Sander W. Spiekstra Taco Waaijman Liselotte Butzelaar Vera L. Negenborn Vivian K. Beekman Erman O. Akpinar Thomas Rustemeyer Frank B. Niessen Susan Gibbs 《Experimental dermatology》2021,30(1):169-178
Unpredictable hypertrophic scarring (HS) occurs after approximately 35% of all surgical procedures and causes significant physical and psychological complaints. Parallel to the need to understanding the mechanisms underlying HS formation, a prognostic tool is needed. The objective was to determine whether (systemic) immunological differences exist between patients who develop HS and those who develop normotrophic scars (NS) and to assess whether those differences can be used to identify patients prone to developing HS. A prospective cohort study with NS and HS groups in which (a) cytokine release by peripheral blood mononuclear cells (PBMC) and (b) the irritation threshold (IT) after an irritant (sodium lauryl sulphate) patch test was evaluated. Univariate regression analysis of PBMC cytokine secretion showed that low MCP‐1, IL‐8, IL‐18 and IL‐23 levels have a strong correlation with HS (P < .010‐0.004; AUC = 0.790‐0.883). Notably, combinations of two or three cytokines (TNF‐a, MCP‐1 and IL‐23; AUC: 0.942, Nagelkerke R2: 0.727) showed an improved AUC indicating a better correlation with HS than single cytokine analysis. These combination models produce good prognostic results over a broad probability range (sensitivity: 93.8%, specificity 86.7%, accuracy 90,25% between probability 0.3 and 0.7). Furthermore, the HS group had a lower IT than the NS group and an accuracy of 68%. In conclusion, very fundamental immunological differences exist between individuals who develop HS and those who do not, whereas the cytokine assay forms the basis of a predictive prognostic test for HS formation, the less invasive, easily performed irritant skin patch test is more accessible for daily practice. 相似文献